From: Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma
Sample | Histologic type | WHO classification1 | TNM2 | Sex | Age | Ethnicity | Origin | History at presentation |
---|---|---|---|---|---|---|---|---|
Tumor FFPE | ||||||||
Tumor 1 | Differentiated | Non-keratinizing | T4N2M0 | M | 46 | Asian | USA | Right sphenoid mass; Right neck mass; bloody nasal discharge; facial numbness; headache |
Tumor 2 | Differentiated | Non-keratinizing | T3N0M0 | F | 80 | Hispanic | USA | Right sphenoid mass; Right neck mass; bloody nasal discharge; facial numbness; headache |
Tumor 3 | Undifferentiated | Non-keratinizing | T4N2M0 | M | 47 | Asian | USA | Large mass involving posterior wall of nasopharynx with superior extension and inferior involvement right oropharyngeal wall |
Tumor 4 | Undifferentiated | Non-keratinizing | T3N1M0 | M | 49 | NA | USA | Right sided 3 cm neck mass; hypermetabolic activity in right nasopharynx on PET/CT |
Control FFPE | ||||||||
Control 1 | Non-neoplastic tissue adjacent to Tumor 1 | Asian | USA | Sinonasal mucosa adjacent to NPC tumor | ||||
Control 2 | Non-neoplastic tissue adjacent to Tumor 2 | Hispanic | USA | Sinonasal mucosa adjacent to NPC tumor | ||||
Control 3 | -- | -- | -- | F | 43 | African-American | USA | Nasal polyposis with chronic rhinosinusitis; large nasopharyngeal mass |
Control 4 | -- | -- | -- | M | 65 | NA | USA | Nasal polyposis with chronic rhinosinusitis; large nasopharyngeal mass |